Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe /

Mostrar otras versiones (1)

Neu entstehende Technologien wie die Biotechnologie stellen eine Kontroverse und Herausforderung für das Patentrecht dar. Das Werk analysiert die neuesten Entwicklungen in der Rechtsprechung zur Zulässigkeit von Patenten im Rahmen der Stammzellen-Forschung in Europa. ReiheMunich Intellectual Prope...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Ugurlu, Ali Seyhan
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Baden-Baden : Nomos Verlagsgesellschaft, 2014.
Colección:Munich Intellectual Property Law Center - MIPLC.
Temas:
Patent laws and legislation > European Union countries.
Embryonic stem cells > Research > Moral and ethical aspects.
Cellules souches embryonnaires > Recherche > Aspect moral.
LAW > Constitutional.
Patent laws and legislation.
European Union countries.
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 JSTOR_ocn890981200
003 OCoLC
005 20231005004200.0
006 m o d
007 cr |n|||||||||
008 140920s2014 gw o 000 0 eng d
040 |a EBLCP  |b eng  |e pn  |c EBLCP  |d YDXCP  |d DEBSZ  |d OCLCQ  |d MERUC  |d AU@  |d OCLCQ  |d JSTOR  |d OCLCO  |d OCLCF  |d VT2  |d ICN  |d C6I  |d OCLCQ  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCQ 
019 |a 907281070  |a 1118504839 
020 |a 9783845255149  |q (electronic bk.) 
020 |a 3845255145  |q (electronic bk.) 
020 |a 9783848714711 
020 |a 384871471X 
029 1 |a AU@  |b 000056015084 
029 1 |a AU@  |b 000065058941 
029 1 |a CHBIS  |b 010404233 
029 1 |a DEBSZ  |b 431762589 
035 |a (OCoLC)890981200  |z (OCoLC)907281070  |z (OCoLC)1118504839 
037 |a 22573/ctv9320xb  |b JSTOR 
043 |a e------ 
050 4 |a KJE2751.B55  |b U38 2014eb 
072 7 |a LAW  |x 018000  |2 bisacsh 
082 0 4 |a 341.7586094 
049 |a UAMI 
100 1 |a Ugurlu, Ali Seyhan. 
245 1 0 |a Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe /  |c Ali Seyhan Uğurlu. 
260 |a Baden-Baden :  |b Nomos Verlagsgesellschaft,  |c 2014. 
300 |a 1 online resource (87 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Munich Intellectual Property Law Center - MIPLC ;  |v v. 22 
588 0 |a Print version record. 
505 0 |a Cover; I. Introduction; II. Background to the Science; A. What Are Stem Cells?; B. Source of stem cells; 1. Adult Stem Cells; 2. ESCs; 3. iPSCs; III. Legal Provisions Applicable to the Patent Eligibility of hESC-Related Inventions; A. EPC; B. TRIPs; C. EC 98/44 Directive; IV. Ethics and Stem Cell Related Patents; A. Ethics and Patent Law; 1. Patent Law Isolated from Morality Based Provisions? A Look into the Legislative Discretion; a) A Closer Look at the EPC; b) Specific Examples of Immorality in the Biotech Directive; B. Bioethics and Patents for hESC-Related Inventions. 
505 8 |a 1. Moral Status of Human Embryos and Its Implications for the hESC Researcha) Debate on whether Human Embryo Has Human Dignity; b) Double-Edged Sword: A Need of Compromise Considering Different Methods of Obtaining hESCs; (1) Research on Embryos Within 14 days After Fertilisation; (2) Research with Supernumerous Embryos; (3) Research with Embryos from SCNT; V. The Panorama in Europe; A. Determining the Right Interpretation of the Biotech Directive; 1. The Patent Eligibility of the Human Embryo; 2. The Patent Eligibility of hESC-related Inventions. 
505 8 |a A) The Destruction of Human Embryos for hESCsb) The Creation of Human Embryos for hESCs; B. Application of the EPC; 1. Lack of Uniform Moral Standard; 2. Attempts to Create a Uniform Morality Standard; VI. EPO's Web of Precedents; A. University of Edinburgh Case; B. The WARF Case; 1. Background; 2. The Rationale; VII. CJEU's Brüstle Judgment; A. Background; B. The Rationale; C. Comparison of WARF and Brüstle Cases; D. The Devil is in Details, Unpatentable but Exploitable?; E. Implications of the CJEU's Judgment to the Future of hESC-Related Inventions; 1. Germany. 
505 8 |a 2. The U.K.3. The EPO; VIII. Conclusion; Annex; List of Works Cited. 
520 |a Neu entstehende Technologien wie die Biotechnologie stellen eine Kontroverse und Herausforderung für das Patentrecht dar. Das Werk analysiert die neuesten Entwicklungen in der Rechtsprechung zur Zulässigkeit von Patenten im Rahmen der Stammzellen-Forschung in Europa. ReiheMunich Intellectual Property Law Center - MIPLC - Band 22. 
590 |a JSTOR  |b Books at JSTOR All Purchased 
590 |a JSTOR  |b Books at JSTOR Open Access 
650 0 |a Patent laws and legislation  |z European Union countries. 
650 0 |a Embryonic stem cells  |x Research  |x Moral and ethical aspects. 
650 6 |a Cellules souches embryonnaires  |x Recherche  |x Aspect moral. 
650 7 |a LAW  |x Constitutional.  |2 bisacsh 
650 7 |a Patent laws and legislation.  |2 fast  |0 (OCoLC)fst01054823 
651 7 |a European Union countries.  |2 fast  |0 (OCoLC)fst01269470 
776 0 8 |i Print version:  |a Ugurlu, Ali Seyhan.  |t Bioethics and the Patent Eligibility of Human Embryonic Stem Cells-Related Inventions in Europe.  |d Baden-Baden : Nomos Verlagsgesellschaft, ©2014  |z 9783848714711 
830 0 |a Munich Intellectual Property Law Center - MIPLC. 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.2307/j.ctv941w4v  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL1778668 
938 |a YBP Library Services  |b YANK  |n 12061868 
994 |a 92  |b IZTAP 

Ejemplares similares